Marketresearchnews

Wednesday, 21 November 2018

Microbiology Testing Market 2018 Share, Trend, Segmentation and Forecast to 2023

Market Scenario

The rising costs of surgeries and overall healthcare has induced the need for hospitals to lean towards technology to reduce the burden. Microbiology Testing (RCM) is a system in the healthcare cycle which relies on electronic health records (EHRs) and automation to expedite outpatient billing and reduce wait times. The global Microbiology Testing market is touted to exhibit a healthy 12.2% CAGR during the assessment period (2017-2027), as per a new market report by Market Research Future (MRFR).

The growing numbers of hospitals and clinics, rising adoption rate of RCM software, recovery audits, and preference for integrated healthcare systems are factors expected to drive market demand during the forecast period.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/697

Key Players for Global Microbiology testing Market:

Alere (US)

BD (US)

Beckman Coulter, Inc. (US)

Cepheid (US)

Thermo Fisher Scientific Inc. (US)

F. Hoffmann-La Roche Ltd (Switzerland)

Biomérieux SA (France)

Segments:

Global Microbiology testing Market has been segmented on the basis of type which comprise Instruments, Chemicals & Reagents, Consumables & Accessories, and others. On the basis of application, it is segmented into, Gastrointestinal Infections, Respiratory Infections, Urinary tract Infections, Sexually Transmitted Infections, Others. On the basis of end user, it is segmented into, Hospital based laboratory, Independent laboratory, and Academics & Research Institutes.

Regional Analysis of Global Microbiology testing Market:

Considering the global scenario of the market, North America was holding largest market share of 37.9% in global Microbiology testing market in 2016. Asia-Pacific is second largest and fastest growing market in global Microbiology testing market. APAC is expected to grow at a CAGR of 12.1% during 2017-2023. Europe was second largest microbiology testing market and is expected to grow at a significantly during the forecast period. On the other hand. Middle East and Africa (ME&A) microbiology testing market was growing lower than global average and expected to grow at steady pace.

Browse Complete 129 Pages Premium Research Report Enabled with 129 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/microbiology-testing-market-697

Detailed Table of Contents:

TABLE OF CONTENTS

1 Report Prologue

2 Introduction

2.1 Scope Of Study 17

2.2 Research Objective 17

2.3 Assumptions & Limitations 17

2.3.1 Assumptions 17

2.3.2 Limitations 17

2.4 Market Structure 18

3 Research Methodology

3.1 Primary Research 21

3.2 Secondary Research 21

3.3 Market Size Estimation 21

3.3.1 Market Share Analysis 22

3.4 Market Pricing Approach 23

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Technological Advancements

4.2.2 Rising Cases Of Infectious Diseases

4.2.3 Surveillance Programs For Disease Control

4.2.4 Rising Stringency Of Standards

4.2.5 Weakness Of Traditional Laboratory Techniques

...Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

UTI Treatment Market 2018 Global– Key Players, Size, Trends, Growth- Analysis To 2023

Urinary tract infection (UTI treatment) is the infection of the lower or upper urinary tract due to bacteria such as Escherichia coli, Staphylococcus saprophyticus etc. The symptoms of UTI treatment are pain with urination, frequent urination and urination feeling despite having an empty bladder. The market driving factors for UTI treatment are female anatomy, sexual intercourse, diabetes, obesity etc. Due to the complications of female anatomy UTI treatment affects females more than males with the World Health Organization (WHO) estimating that approximately 50 % of women suffer from UTI treatment at some point of time in their lives resulting in more than 1 million hospitalizations per year. It has further been stated that 1% of boys and 3-8% of girls are diagnosed with UTI treatment and the annual cost of UTI treatment infections treatment to be greater than $1 billion.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3146

The Global urinary tract infection (UTI treatment) drugs market is growing due to factors such as rise in hospital borne infections (nosocomial infections), child birth, old age, obesity, growing health awareness especially about women health etc. However the fastest growth has been registered due to rising use of catheters (catheter associated UTI treatment).

The market constraints include growing drug resistance, unmet clinical needs, increasing incidence of chronic diseases resulting in chronic catheter use and low immunity etc. Taking all these factors into consideration, the Global UTI treatment drugs market will approximately reach to $ 9.89 billion in 2023 from $ 8 billion in 2016 growing at a CAGR of 3.6%.

Key players of Global UTI treatment Market

· Bayer AG

· Novartis AG

· Pfizer Inc.

· F. Hoffmann-La Roche Ltd

· AstraZeneca

· Cipla Inc.

· Dr. Reddy’s Laboratories Ltd.

· Johnson & Johnson GlaxoSmithKline

Segmentation

The Global UTI treatment Market is segmented on the basis of drug class which comprises of quinolones, aminoglycosides, β-lactam, azoles and others. On the basis of clinical indications this market is segmented into urethritis, cystitis, and pyelonephritis. On the basis of end users the market is segmented into hospitals and self-administered.

Regional analysis

U.S. accounts for the largest market share of the global UTI treatment market followed by Europe. However Europe has a greater hospitalization rate than the U.S. despite the U.S. having a large spending on healthcare. The regulatory changes in the U.S. such as implementation of Affordable Care Act and Hospital Readmissions Reduction Program coupled with Medicare initiative to penalize unnecessary patient readmissions is expected to take a toll on the U.S UTI treatment market. Asia pacific will be the fastest growing market and the growth will be led by China, and India as these nations have huge population and the low cost of UTI treatment drugs.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/3146

Detailed Table of Contents:

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s Five Forces Model

4.1.1 Bargaining Power Of Suppliers

4.1.2 Bargaining Power Of Customer

4.1.3 Intensity Of Competitor’s

4.1.4 Threat Of New Entrants

...Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/3146

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Eye Care Supplements Market Trends, Size and Growth Analysis 2018 To 2023

Market Synopsis of the Global Eye Care Supplements Market
The market for eye care supplements is expected to growth at an exponential rate owing to an increasing prevalence of eye diseases and chronic diseases such as diabetes, which are risk factors for eye disease. Furthermore, demand for eye care solutions is increasing across the globe. Therefore, majority of the market players have great opportunities in this market by using strategic approaches such as geographical expansion.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4457

Eye care supplements are products containing vitamins and other nutrients that are useful for maintaining eye health and good vision. They improve eye health and can be used for the treatment of a number of related diseases such as cataracts, diabetic retinopathy, and glaucoma. Many people face the problem of poor vision. The primary method of improving the vision is use of dietary products extracted from both natural and synthetic sources such as plants. Antioxidants, omega fatty acids are the most widely used eye care supplements across the globe.

Market Dynamics

Growing Eye Diseases and Disorders Is The Prime Determinant Of The Market Growth

According to the World Health Organization (WHO) estimates, about 285 million people are visually impaired worldwide. According to the Royal National Institute of Blind People (2016), the number of people living with sight loss is expected to reach 2.7 million by 2030 due to possible cases of refractive error, cataract, glaucoma, and others. According to the National Eye Institute, the number of people in the U.S. with cataract is projected to double from 24.5 million in 2010 to 50 million by 2050. Moreover, in 2015, National Eye Institute stated that more than half of the Americans suffer from cataract-related problems in their lifespan.

Growing Awareness And Geriatric Population Is Charging A High Market Demand

According to the Economic and Social Commission estimates for Asia and the Pacific, in 2016 about 12.4 % of the population within the region aged 60 or more and this geriatric population is projected to reach 1.3 billion by 2050. Increasing prevalence of eye diseases and chronic diseases such as diabetes, which are risk factors for eye disease is another driver of the market.

High Cost And Lack Of Healthcare Coverage And Infrastructure In Developing Regions Expected To Hamper Market Growth

The high cost of eye care supplements may restrain the market growth, especially in the developing countries.

Segments
The global eye care supplements market is segmented on the basis of type, application, and end user.

On the basis of type, market is segmented into Antioxidant, Fatty acids, anti-inflammatory supplements, neuro-protective supplements and others. Antioxidant segment is further segmented into water -soluble antioxidants including lutein, zeaxanthin, astaxanthin, and fat-soluble antioxidants including astaxanthin. Fatty acids segment is further segmented into omega-6 gamma-linolenic acid. Anti-inflammatory supplements segment is further segmented into docosahexaenoic acid (DHA). Neuro-protective segment is further segmented into eicosapentaenoic acid (EPA).

On the basis of application, the market is segmented into eye health, macular degeneration, cataract, Diabetic retinopathy, glaucoma, and others.

On the basis of end user, the market is segmented into eye hospitals, eye clinics, and others.

Key Players
Some of the key players in this market are Biosyntrx Inc. (U.S.), Nordic Naturals Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Healths Harmony USA Supplements LLC (U.S), NUSAPURE (U.S.), Vitabiotics Ltd. (U.K), and Bausch & Lomb Incorporated. (U.S.).

Regional Analysis
America is the largest market for eye care supplements owing to an increasing demand for eye care supplements and rising prevalence of vision impairment and problems among people in the US. According to the Center of Disease Control and Prevention, nearly 14 million Americans aged 12 years and older have some form of visual impairment.

According to the World Health Organization, about 60 million European have diabetes and the prevalence of diabetes is relatively high among people over 25 years.

Europe is the second largest market for eye care supplements which will steady growth in the near future du rot the availability of cost effective treatments and prevention strategy.

The Middle East & Africa also show a steady rise in the market owing to rise in the demand for ophthalmic products and available treatment options.

In Asia Pacific, the market is expected grow at a fastest rate owing to an increasing prevalence of chronic disease such as diabetes, diabetic retinopathy and obesity.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4457

Detailed Table of Contents:

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs Of The Market

12.2 Key Companies To Watch

12.3 Prediction Of Pharmaceutical Industry

13 Appendix

LIST OF TABLES

Table 1 Eye Care Supplements Industry Synopsis, 2017-2023

Table 2 Global Eye Care Supplements Market Estimates And Forecast, 2017-2023, (USD Million)

Table 3 Global Eye Care Supplements Market By Region, 2017-2023, (USD Million)

Table 4 Global Eye Care Supplements Market By Types, 2017-2023, (USD Million)

Table 5 Global Eye Care Supplements Market By Application, 2017-2023, (USD Million)

...Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4457

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Eye Allergy Treatment Market 2018 Global Analysis, Opportunities and Forecast to 2023

Eye allergies affect a huge number of individuals each year also, are portrayed by an overcompensation of the immune system to an allergen through eating, touching or breathing it into the lungs. Eye allergies are one of the most common health problems across the globe. Approximately 50 million people have some or the other kind of eye allergy in US alone. Eye allergy are regularly joined by nasal allergy symptoms, for example, wheezing and sneezing, however can likewise happen alone. Allergens are found inside and outside. Grass, tree and wood dusts are the most widely recognized open air allergens, while the most basic indoor allergens incorporate pet hair (dander), clean bugs and molds.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3811

The eye allergy treatment market is expected to grow at a steady pace. The factors influencing the growth of the market include rising prevalence of numerous eye allergies are major driver for the market while some other factors like growing awareness, technological advancements, new therapies, and growing healthcare expenditure are also major driving influencing the global eye allergy treatment market.

The global eye allergy treatment market is expected to grow at the CAGR of ~5.2% during the forecast period and estimated to reach US$ 6845.3million by 2023.

Eye allergies are one of the most common health problems across the globe. Approximately 50 million people have some or the other kind of eye allergy in US alone. Some of the common eye allergy symptoms are redness, itching, and burning.

Increasing prevalence of various eye allergies are key driver for the market while some other factors like increasing awareness, technological advancements, new therapies, and increasing healthcare expenditure are also major driving forces of global eye allergy treatment market.

Key Players for Global Eye Allergy Treatment Market:

Some of the key players in this market are:

Johnson & Johnson Vision Care, Inc. (US),
Merck & Co., Inc. (US),
Pfizer Inc. (US),
Regeneron Pharmaceuticals, Inc. (US),
Hoffmann-La Roche Ltd (Switzerland),
ALLERGAN (Republic of Ireland),
Novartis AG (Switzerland),
Santen Pharmaceutical Co., Ltd.(Japan),
Valeant (Canada)
Shire (Republic of Ireland), and others.

Regional Analysis Of Global Eye Allergy Treatment Market:

Considering the global scenario of the market, the Americas dominate global market due to various factors such as large amount of money invested in R&D, new approvals for various dugs and medicine etc. European market is second largest and is expected to grow significantly during the forecast period. Due to rapidly developing healthcare facilities, rising healthcare expenditure, increasing investment in technology advancement, Asia Pacific region is the fastest growing in global eye allergy market. Middle East & Africa market is also growing but is expected to grow slower than the global average.

Segmentation Of Global Eye Allergy Treatment Market:

On the basis of end user, it is segmented into eye hospitals & clinics, medical institutes, research centers, and others.

Global Eye Allergy Treatment market has been segmented on the basis of type which comprise seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, contact allergic conjunctivitis, giant papillary conjunctivitis, and others. Vernal keratoconjunctivitis includes palpebral, limbal, corneal, and others.

On the basis of treatment, the market has been segmented into medication, allergy shots (immunotherapy), and others. Medication includes artificial tears, decongestants, oral antihistamines, antihistamine/mast-cell stabilizers, corticosteroids. Decongestants are further sub-segmented into with or without antihistamines. Allergy shots (immunotherapy) is sub-segmented into Subcutaneous Immunotherapy Treatment (SCIT) and Sublingual Immunotherapy Treatment (SLIT).

Browse Complete 76 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/eye-allergy-treatment-market-3811

Detailed Table of Contents:

Report Prologue
Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

Competitive Landscape
Company Profile
Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs Of The Market

13.2 Key Companies To Watch

13.3 Prediction Of Eye Allergy Treatment Market

Appendix

...Continued!

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com